RayzeBio, Inc. (RYZB) Misses Q3 EPS by 57c

RayzeBio, Inc. (NASDAQ: RYZB) reported Q3 EPS of ($1.26), $0.57 worse than the analyst estimate of ($0.69).

For earnings history and earnings-related data on RayzeBio, Inc. (RYZB) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• Ennis (EBF) Misses Q2 EPS by 2c
• Goldman: 'Our key conclusion is that AI is likely to be credit-positive for banks', 'Rearming Our Overweight Stance on Banks'